T1	disease_or_phenotypic_feature 69 74	tumor
T2	chemical 96 109	drug-agnostic
T3	chemical 130 134	drug
T4	disease_or_phenotypic_feature 135 143	modifier
T5	disease_or_phenotypic_feature 175 184	sensitive
T6	chemical 196 203	protein
T7	disease_or_phenotypic_feature 286 297	thyroiditis
T8	chemical 286 297	thyroiditis
T9	disease_or_phenotypic_feature 334 340	common
T10	disease_or_phenotypic_feature 444 454	thrombosis
T11	chemical 491 496	group
T12	disease_or_phenotypic_feature 524 534	thrombosis
T13	chemical 575 584	molecular
T14	disease_or_phenotypic_feature 604 612	diseases
T15	chemical 717 728	Polyphenols
T16	disease_or_phenotypic_feature 768 778	Depression
T17	disease_or_phenotypic_feature 829 838	PITUITARY
T18	chemical 879 890	BIOCHEMICAL
T19	disease_or_phenotypic_feature 923 926	MEN
T20	disease_or_phenotypic_feature 932 962	HYPOGONADOTROPIC HYPOGONADISM.
T21	chemical 1115 1119	lead
T22	disease_or_phenotypic_feature 1135 1141	trauma
T23	disease_or_phenotypic_feature 1219 1230	Mono-Kinase
T24	chemical 1278 1288	Inhibitors
T25	chemical 1313 1320	Protein
T26	chemical 1410 1428	physiological role
T27	disease_or_phenotypic_feature 1513 1526	breast cancer
T28	disease_or_phenotypic_feature 1569 1574	tumor
T29	disease_or_phenotypic_feature 1668 1692	hepatocellular carcinoma
T30	disease_or_phenotypic_feature 1694 1700	Hep-3B
T31	chemical 1748 1758	superoxide
T32	chemical 1759 1764	anion
T33	chemical 1824 1835	chloroquine
T34	chemical 1840 1850	primaquine
T35	disease_or_phenotypic_feature 1874 1881	disease
T36	missed_disease_or_phenotypic_feature 1910 1922	parasitaemia
T37	chemical 1964 1975	clopidogrel
T38	disease_or_phenotypic_feature 1994 2000	common
T39	chemical 2017 2027	ticagrelor
T40	disease_or_phenotypic_feature 2068 2072	ESRD
T41	chemical 2138 2146	silicone
T42	disease_or_phenotypic_feature 2177 2183	trauma
T43	disease_or_phenotypic_feature 2239 2247	glaucoma
T44	chemical 2335 2340	group
T45	chemical 2464 2468	food
T46	disease_or_phenotypic_feature 2499 2503	MDD.
T47	corrected_chemical 2584 2604	mTOR/TORC1 inhibitor
T48	chemical 2595 2604	inhibitor
T49	chemical 2605 2615	everolimus
T50	disease_or_phenotypic_feature 2619 2622	men
T51	corrected_disease_or_phenotypic_feature 2628 2653	high-risk prostate cancer
T52	disease_or_phenotypic_feature 2638 2653	prostate cancer
T53	chemical 2665 2672	radical
T54	chemical 2717 2731	lipoprotein[a]
T55	disease_or_phenotypic_feature 2739 2761	cardiovascular disease
T56	chemical 2843 2847	lead
T57	disease_or_phenotypic_feature 2976 2983	disease
T58	chemical 3073 3082	molecular
T59	chemical 3149 3156	protein
T60	disease_or_phenotypic_feature 3197 3209	hip fracture
T61	disease_or_phenotypic_feature 3249 3252	BMD
R1	treats Arg1:T34 Arg2:T35
R2	treats Arg1:T34 Arg2:T36
R4	treats Arg1:T33 Arg2:T35
R5	treats Arg1:T33 Arg2:T36
T62	missed_chemical 2032 2041	prasugrel
R7	treats Arg1:T62 Arg2:T40	
R8	treats Arg1:T39 Arg2:T40	
R9	treats Arg1:T37 Arg2:T40	
R10	causes_or_contributes_to Arg1:T54 Arg2:T55	
T63	missed_disease_or_phenotypic_feature 2763 2766	CVD
T64	missed_chemical 2710 2715	Lp(a)
R11	causes_or_contributes_to Arg1:T64 Arg2:T55	
R12	causes_or_contributes_to Arg1:T54 Arg2:T63	
R13	causes_or_contributes_to Arg1:T64 Arg2:T63	
T65	missed_chemical 1634 1640	vaspin
R14	causes_or_contributes_to Arg1:T65 Arg2:T29	
R15	causes_or_contributes_to Arg1:T65 Arg2:T30	
T66	missed_chemical 1624 1633	adipokine
R16	causes_or_contributes_to Arg1:T66 Arg2:T29	
R17	causes_or_contributes_to Arg1:T66 Arg2:T30	
T67	corrected_chemical 3149 3185	protein intake above the current RDA
R18	treats Arg1:T67 Arg2:T60	
